Sunrise Oncology Partners
233 Spring Street
New York, NY 10013
P: (212) 123­1223
F: (212) 123­1224
Patient Nam e:  Mott, Elizabeth 
Patient Number: 12345678Date: 05/08/2018
Date Of Birth:   08/29/1960
Date Type Details Outcome Comment
5/1/2018 Other Therapies Synthroid 175 mcg tablet Active
5/1/2018 Other Therapies Zoloft 50 mg tablet Active
Allergies
No known allergies have been entered for this patient.
Medical and Surgical History
Hypothyroidism. Mild anxiety.
Date Type ICD­9 ICD­10 Problem Comment Status
Date Type Details Outcome Comment
9/18/2018 Surgery Tonsillectomy 1960s
Social History
Patient is married.  No history of tobacco use.  Mrs. Mott reports the following support system: lives with fam ily. Her diet consists of 
regular meals. She indicates her daily activity level as: daily activities.
Alco
hol Use: Yes, Weekly.
Family History
Reviewed and unchanged.
Gyn History
Menarche at the age of 12. LMP more than 10 years ago.
Revi
ew Of Systems
Con
stitutional Symptoms: Patient reports:  no fatigue,  no weakness,  no weight loss,  no fevers,  no chills,  no diaphoresis,  no night 
sweat s , no hot flashes.  exertional dyspnea, no cough
Eyes: Patient offers no eye complaints. 
Gastrointestinal : Patient offers no gastrointestinal complaints.  no nausea,   no vomiting,  no dysphagia,   no abdominal pain,  no diarrhea,  no 
constipation
Musculoskeletal: bone pain,  no back pain,  no arthralgia  
Integumentary: Patient reports: no rash, no pruritis, no skin lesions, no dry skin
Page 1 of 2  
FOLLOW UP VISIT
Chief Complaint
Mrs. Mott is a 57 year old woman who was diagnosed with breast c ancer in April 2018. Wor kup revealed extensive bone 
metastases, adenopathy and hepatic lesions. Tumor was  biopsied showing ER positive, PR positive, Her 2 amplified breast 
cancer. She is here to initiate systemic therapy.
On-going Treatment  EventsNeurological: Patient reports: no headache, no peripheral neuropathy, no focal weakness, no tremor, no altered consciousness, n
oseizures, no speech impairment, no dizziness.  no paralysis,  nervousness,
Vital Signs
Vitals on  5/8/18  12:29:00 PM: Height=66in, Weight=155lb, Pulse=74, SystolicBP=122, DiastolicBP=68  
Physical  Exam
General:  Patient appear s: well developed and well nourished,  No alopecia noted.  
Eyes: No scleral icterus, and/or pallor. Conjunctiva clear. EOM s intact. Pupils  equal and reactive to light. 
Cardiovascular:  Heart with regular rate and rhythm. Normal S1 and S2. S3, S4 No gallop. No rubs or clicks. No bruits. Pedal pulses  
present. 
Chest: Clear no rales /rhonchi. No dullness to percussion. No wheezing. Chest wall expansion normal. No c hest wall tenderness. No  
stridor. 
Abdomen:  Soft. Non­tender. Non­dis tended. No palpable masses. No ascites. No hepatosplenomegaly. Bowel sounds  present in all  
quadrants. No hernia. 
Hematologic/
Lymphatic:  No cervical lymphadenopathy . No supraclavicular  lymphadenopathy. No axillar y lymphadenopathy. No inguinal  
lymphadenopathy . No petec hiae. No ecchy mosis. 
Skin: No rashes. No lesions.  Extremities appear normal. No evidence of cyanosis.  No edema.  No clubbing present. 
Neurologic:  Alert and oriented.  Normal speech.  Cranial nerves in tact.  
Genitourinary:  Examination deferred.  
Rectal: Examination deferred.  
Gynecological:  Examination defer red.
Laboratory Results
Lab res ults on 5/8/2018: Sodium=135 mmol/L, Potassium=4.2 mmol/L, CO2=31 mmol/L, Chloride=99 mmol/L, Gluc ose= 84 m g/dL, 
Calcium=9.0 mg/dL, BUN=14 mg/dL, Creat=1.1 mg/dL, A lk Phos=45 U/L, ALT=21 U/L, AST=23 U/L, Total B ili=0.9 m g/dL, Albumin=3.7g 
dL, Total Protein=7.5 g/dL. WBC=4.1 x10E3/uL, RB C=4.63 x10E 6/uL, HGB=9.9 g/dL, HCT=31.4%, MCV=68 fL, MCH= 21.4 pg, 
MCHC=31.5 g/dL, RDW=16.1 %, Plat=179 x10E3/uL, ANC= 2.8 x 10E3/uL, Lym ph#=1.0 x10E3/uL, MONO#=0.2  x10E3/uL, BASO#=0.1 
x10E3/uL, EOS#=0.1 x10E3/uL, MONO%=5 %, BASO%=1 %, EOS%=1 %, Neut%=68 %
Imaging Results
Radiology results were reviewed and discussed with the patient, including 4/2018-  MRI Brain no m etastasis deep white matter changes 
suggestive of inflammatory process. PET/CT - left br east m ass; diffuse bone metastases; liver lesions s uspicious for metastatic breas t 
cancer.
Primary Dx 
198.5 - Secondary malignant neoplasm of bone and bone m arrow, Diagnosed Apr 2018
174.9 - Malignant neoplas m of breast (female), unspec ified site, Diagnosed A pr 2018
Assessment
Stage 4  ER HER2 positive breast cancer with adenopathy, bone and liver metastases. Patient had a negative brain MRI.  Testing of 
tumor demonstrates ER+ PR+. HER2neu equivoc al on IHC. FISH positive. Patient is her e to star t systemic therapy with TH P. I have 
discussed the PET/CT results with her and her family in great detail. I will s ee her back with her next cycle, sooner if she has any 
problems.
Recommendation/Plan
Time spent with patient was  35 minutes. Over half the time was spent  counseling and coordinating care, which included the  
following:
Arranged patient treatment education.
Reviewed with patient  treatment s ide effects.
Supportive measures  reviewed.
Begin Taxol, Herceptin and Perjeta.
All questions answered.
Page 2 of 2  Electronically signed:DATE May 8, 2018  
TIME 1:09PM  
Shannon Wu, M.D.
